maat033

Cell therapyexperimental

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Mar 31, 2020 (NCT04150393)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05762211Phase 2Oct 31, 2023MaaT Pharma, University of Paris
NCT05889572Phase 1Jun 8, 2023MaaT Pharma
NCT04150393Phase 1Mar 31, 2020IUCT, MaaT Pharma
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MaaT PharmaFor profit3322020
IUCTAcademic/Hospital1012020
University of ParisAcademic/Hospital1012023
3 organizations
Page 1 / 1